The National Cancer Institute (NCI) announced the launch of their pilot Bridge Award Program and is seeking applications from small business concerns (SBC). This program is designed to address the funding gap known as the "valley of death" between the end of a Phase II award and product commercialization for those developing cancer therapies or cancer imaging technologies. Previously funded Phase II applicants in this space are encouraged to apply. Award requests of $1M per year for up to 3 years are allowed. While those with matching funds will be given priority, a match from a third party investor or strategic partner is not required. This program is designed to attract third party investment in this capital intensive phase of commercialization. For more information on the program please click here.